Ocular Bioavailability
Ocular Bioavailability is the fraction of an administered ophthalmic drug that reaches the systemic circulation or target ocular tissues in an active form, distinguishing it from other pharmacokinetic parameters by specifically quantifying the extent of drug absorption and availability within ocular structures following ocular administration.
1.1K
Publications
45.9K
Citations
4K
Authors
1K
Institutions
Publications per year
2017–2026
305
Children
Anterior Segment BioavailabilityIntravitreal BioavailabilityIonization Effects On Ocular AbsorptionLipophilicity Effects On Ocular AbsorptionMolecular Weight Effects On Ocular AbsorptionMucoadhesive Ocular FormulationsOcular Drug Retention SystemsOcular Mucosal AbsorptionOcular Permeation EnhancersPermeation Through The Blood-retinal Barrier
1.1K
Amalia Enríquez‐de‐Salamanca, Yolanda Diebold, Margarita Calonge et al. · Investigative Ophthalmology & Visual Science · 2006 · 282 citations
1–5 of 1.1K
4K
25
h-index
14
h-index
13
h-index
13
h-index
12
h-index
1–5 of 4K
1K

University of Eastern Finland
Joensuu, Finland
26 h-index
165 publications
7.3K citations

University of Helsinki
Helsinki, Finland
20 h-index
53 publications
2.3K citations

Cairo University
Giza, Egypt
18 h-index
51 publications
2.8K citations
Allergan (United States)
Madison, United States
18 h-index
51 publications
2.5K citations
University of Southern California
Los Angeles, United States
17 h-index
51 publications
2.3K citations
University of Missouri–Kansas City
Kansas City, United States
17 h-index
52 publications
2.2K citations
Allergan (Ireland)
Westport, Ireland
16 h-index
52 publications
2.3K citations
University of Wisconsin–Madison
Madison, United States
14 h-index
27 publications
2.1K citations
1–8 of 1K
OPT · 122 publications · 3.5K citations
34
h-index
63 publications · 3K citations
33
h-index
Repository · 74 publications · 2.9K citations
31
h-index
IOVS · 37 publications · 2.8K citations
27
h-index
39 publications · 2.1K citations
26
h-index
1–5